Zhong LI

Dr. Zhong LI


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2024 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
JYJinghong Yang
Jinghong Yang
JZJun Zhong
Jun Zhong
HLHan Li
Han Li
YDYimin Du
Yimin Du
XLXu Liu
Xu Liu
YLYanshi Liu
Yanshi Liu
Medial patellar ligament reconstruction (MPFL-R) in combination with derotational distal femoral osteotomy (DDFO) for treating recurrent patellar dislocation (RPD) in the presence of increased femoral anteversion is one of the most commonly used surgical techniques in the current clinical practice. However, there are limited studies on the clinical outcomes of MPFL-R in combination with DDFO to treat RPD in the presence of increased femoral anteversion. To study the role of MPFL-R in combination with DDFO in the treatment of RPD in the presence of increased femoral anteversion. A systematic review was performed according to the PRISMA guidelines by searching the Medline, Embase, Web of Science, and Cochrane Library databases through June 1, 2023. Studies of patients who received MPFL-R in combination with DDFO after presenting with RPD and increased femoral anteversion were included. Methodological quality was assessed using the MINORS (Methodological Index for Nonrandomized Studies) score. Each study’s basic characteristics, including characteristic information, radiological parameters, surgical techniques, patient-reported outcomes, and complications, were recorded and analyzed. A total of 6 studies with 231 patients (236 knees) were included. Sample sizes ranged from 12 to 162 patients, and the majority of the patients were female (range, 67-100%). The mean age and follow-up ranges were 18 to 24 years and 16 to 49 months, respectively. The mean femoral anteversion decreased significantly from 34° preoperatively to 12° postoperatively. In studies reporting preoperative and postoperative outcomes, significant improvements were found in the Lysholm score, Kujala score, International Knee Documentation Committee score, and visual analog scale for pain. Postoperative complications were reported in all studies, with an overall reported complication rate of 4.7%, but no redislocations occurred during the follow-up period. For RPD with increased femoral anteversion, MPFL-R in combination with DDFO leads to a good clinical outcome and a low redislocation rate. However, there was no consensus among researchers on the indications for MPFL-R combined with DDFO in the treatment of RPD.

24 June 2024 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
JZJun Zhong
Jun Zhong
HYHui Yuan
Hui Yuan
JYJinghong Yang
Jinghong Yang
YDYimin Du
Yimin Du
ZLZheng Li
Zheng Li
YLYanshi Liu
Yanshi Liu
Sarcopenia is a condition characterized by age-related loss of muscle mass and strength. Increasing evidence suggests that patients with sarcopenia have higher rates of coronavirus 2019 (COVID-19) infection and poorer post-infection outcomes. However, the exact mechanism and connections between the two is unknown. In this study, we used high-throughput data from the GEO database for sarcopenia (GSE111016) and COVID-19 (GSE171110) to identify common differentially expressed genes (DEGs). We conducted GO and KEGG pathway analyses, as well as PPI network analysis on these DEGs. Using seven algorithms from the Cytoscape plug-in cytoHubba, we identified 15 common hub genes. Further analyses included enrichment, PPI interaction, TF-gene and miRNA-gene regulatory networks, gene-disease associations, and drug prediction. Additionally, we evaluated immune cell infiltration with CIBERSORT and assessed the diagnostic accuracy of hub genes for sarcopenia and COVID-19 using ROC curves. In total, we identified 66 DEGs (34 up-regulated and 32 down-regulated) and 15 hub genes associated with sarcopenia and COVID-19. GO and KEGG analyses revealed functions and pathways between the two diseases. TF-genes and TF-miRNA regulatory network suggest that FOXOC1 and hsa-mir-155-5p may be identified as key regulators, while gene-disease analysis showed strong correlations with hub genes in schizophrenia and bipolar disorder. Immune infiltration showed a correlation between the degree of immune infiltration and the level of infiltration of different immune cell subpopulations of hub genes in different datasets. The ROC curves for ALDH1L2 and KLF5 genes demonstrated their potential as diagnostic markers for both sarcopenia and COVID-19. This study suggests that sarcopenia and COVID-19 may share pathogenic pathways, and these pathways and hub genes offer new targets and strategies for early diagnosis, effective treatment, and tailored therapies for sarcopenia patients with COVID-19.

22 September 2025 in International Journal of Bioprinting
Verified
Journal Article
Open access
PDF file
JYJinghong Yang
Jinghong Yang
ZWZi Wang
Zi Wang
LJLujun Jiang
Lujun Jiang
ZLZhong LI
Zhong LI
LLLinlin Liu
Linlin Liu
JLJuncai Liu
Juncai Liu
Ti6Al4V scaffolds demonstrate significant translational potential for bone defect reconstruction, leveraging exceptional biocompatibility and corrosion resistance. However, achieving concurrent osseointegration enhancement and mechanical compatibility with native cancellous bone remains a critical design constraint. A trabecular bone-mimetic porous Ti6Al4V scaffold was fabricated via Voronoi-tessellated CAD and selective laser melting (SLM). Precise modulation of pore architecture enabled controlled porosity. Compression testing characterized the mechanical properties. Early-stage in vivo osseointegration was evaluated in a rabbit femoral condyle defect model using histomorphometry and micro-computed tomography (μCT) at 4/12 weeks, with comparative assessment against conventional Strut-based and G-curved lattices. The Voronoi scaffold exhibited cancellous bone-matching elastic modulus and yield strength, thereby mitigating stress-shielding effects. Biomechanics, CFD, and in vivo analysis demonstrated significantly enhanced osteogenic potential and superior bone-implant interface integration versus Strut and TPMS designs. The Voronoi design provides an effective biomimetic strategy for fabricating porous titanium alloy bone scaffolds with enhanced osteogenic properties. It has more potential than conventional struts and periodic TPMS structures in facilitating bone defect repair.

22 November 2024 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
ZRZhiqiang Ren
Zhiqiang Ren
JYJinghong Yang
Jinghong Yang
ZWZi Wang
Zi Wang
LJLujun Jiang
Lujun Jiang
LTLian Tang
Lian Tang
ZLZhong LI
Zhong LI
Bone defects and nonunion following initial treatment remain significant clinical challenges. The Ilizarov method constitutes a fundamental approach for addressing bone defects, and its integration with adjunctive techniques, such as the accordion maneuver, antibiotic spacers, or internal fixation, has become increasingly widespread. Despite this, limited research exists on the clinical outcomes specifically related to the use of the Ilizarov method combined with the accordion technique for treating long bone defects in the lower limbs. This study seeks to systematically review the application of the Ilizarov method in combination with the accordion technique for addressing long bone deficiencies in the lower limbs. Systematic review; Level of evidence, 4. A systematic review was performed in alignment with the PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-Analyses), involving searches of Medline, Embase, Web of Science, and the Cochrane Library, with the search process concluding on August 20, 2024. The study population consisted of patients with bone defects who underwent treatment using the Ilizarov method in conjunction with the accordion technique. The methodological quality of the included studies was evaluated using the MINORS (Methodological Index for Non-Randomized Studies) scoring system. This study recorded and analyzed the participant count for each study that met the inclusion criteria, along with the number of patients who achieved bone healing, the bone and functional outcomes, and complications such as pin infections, pain, and refracture. Drawing from eight studies involving 80 patients with bone defects treated through the Ilizarov method combined with the accordion technique, this systematic review evaluated the method’s impact on bone regeneration. Of these patients, 24% presented with femoral defects, while 76% had tibial defects. The mean patient age was 32.8 years, with an average follow-up of 25.2 months. The accordion technique involved daily distraction and compression adjustments ranging from 0.25 to 1 mm, typically in more than two cycles, effectively promoting bone healing. The bone healing rate was high, with the majority of patients rated as having excellent or good functional recovery, according to standards such as ASAMI and Paley. Common complications included superficial pin tract infections (33.75%) and deep pin tract infections (6.25%), both of which were generally manageable with routine treatment. The accordion technique showed promising results in shortening healing time and enhancing the quality of bone healing. This systematic review demonstrates that despite variations in parameter settings across studies, the Ilizarov method combined with the accordion technique consistently shows strong efficacy and safety in promoting bone regeneration and functional recovery. While some complications may arise, they are generally well-managed with standard care. This approach represents a reliable option for complex bone reconstruction, with future research needed to optimize parameters and further enhance clinical outcomes.

23 June 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
LJLujun Jiang
Lujun Jiang
JSJuncheng Shen
Juncheng Shen
JYJinghong Yang
Jinghong Yang
ZWZi Wang
Zi Wang
LTLian Tang
Lian Tang
YLYanshi Liu
Yanshi Liu
Background: Acetyl tributyl citrate (ATBC) is a widely used environmental plasticizer that has raised concerns regarding its potential health effects, particularly its role in cancer development. Although ATBC is generally considered to have a safer profile compared to traditional phthalate-based plasticizers, research on its association with bone cancer remains limited. The aim of this study is to elucidate the complex effects of Acetyl tributyl citrate (ATBC) on bone cancer and to unravel the potential molecular mechanisms by which environmental pollutants influence the disease process.Methods: This study utilized multiple online databases to identify target genes associated with ATBC and bone cancer. Initially, protein–protein interaction (PPI) analysis and visualization of the intersecting genes were performed. Subsequently, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analyses were conducted to explore the underlying mechanisms connecting the two conditions. Finally, molecular docking was employed to validate the interactions between these compounds and their respective targets.Results: Using the CHEMBL, SwissTarget Prediction, and TargetNet databases, we screened 193 genes associated with ATBC. Additionally, we identified 4,439 genes related to bone cancer through the GeneCards, OMIM, and TTD databases, resulting in 73 intersecting genes. After rigorous refinement utilizing the STRING platform and Cytoscape software, we identified five core targets: STAT3, EGFR, MMP9, MAPK1, and MMP2. Functional enrichment analysis indicated that the core targets of ATBC’s influence on bone cancer are primarily involved in the regulation of apoptosis, carcinogenesis, and cellular proliferation, among other biological processes. Finally, molecular docking simulations conducted with AutoDock confirmed robust binding interactions between ATBC and these core targets, thereby enhancing our understanding of their interactions.Conclusion: This study underscores the potential carcinogenic effects of ATBC in bone cancer, identifying key targets such as STAT3, EGFR, MMP9, MAPK1, and MMP2. The findings indicate that ATBC may facilitate the progression of bone cancer by targeting essential signaling pathways and remodeling the tumor microenvironment. This emphasizes the necessity for further research into the environmental risks associated with this plasticizer.

18 June 2024 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
JYJinghong Yang
Jinghong Yang
JZJun Zhong
Jun Zhong
YDYimin Du
Yimin Du
ZWZi Wang
Zi Wang
LJLujun Jiang
Lujun Jiang
YLYanshi Liu
Yanshi Liu
Sarcopenia, a geriatric syndrome characterized by progressive loss of muscle mass and strength, and osteoarthritis, a common degenerative joint disease, are both prevalent in elderly individuals. However, the relationship and molecular mechanisms underlying these two diseases have not been fully elucidated. In this study, we screened microarray data from the Gene Expression Omnibus to identify associations between sarcopenia and osteoarthritis. We employed multiple statistical methods and bioinformatics tools to analyze the shared DEGs (differentially expressed genes). Additionally, we identified 8 hub genes through functional enrichment analysis, protein–protein interaction analysis, transcription factor-gene interaction network analysis, and TF-miRNA coregulatory network analysis. We also discovered potential shared pathways between the two diseases, such as transcriptional misregulation in cancer, the FOXO signalling pathway, and endometrial cancer. Furthermore, based on common DEGs, we found that strophanthidin may be an optimal drug for treating sarcopenia and osteoarthritis, as indicated by the Drug Signatures database. Immune infiltration analysis was also performed on the sarcopenia and osteoarthritis datasets. Finally, receiver operating characteristic (ROC) curves were plotted to verify the reliability of our results. Our findings provide a theoretical foundation for future research on the potential common pathogenesis and molecular mechanisms of sarcopenia and osteoarthritis.